阅读说明：本技术 防治nitm 的药物组合物及其医药用途 (Pharmaceutical composition for preventing and treating NITM and medical application thereof ) 是由 刘继东 王宁利 郭雷 杨强 高坤 李林蔚 顾红 孙洋 付乐 于 2018-11-05 设计创作，主要内容包括：本发明属于医药领域,涉及一种防治NITM的药物组合物及其医药用途。具体地,所述药物组合物为眼用药物组合物例如眼用制剂。具体地,本发明涉及一种药物组合物,其包含0.001％－0.2％的阿托品或其可药用盐,以及一种或多种药学上可接受的辅料；其中,所述药物组合物的pH值为4.0－6.5；所述药物组合物包含0.5％－5％的pH调节剂,所述pH调节剂选自磷酸二氢钠、磷酸氢二钠、枸橼酸、枸橼酸盐、硼酸和硼酸盐中的任意一种或多种。本发明的药物组合物能够有效地治疗和/或预防NITM,具有良好的应用前景。(The invention belongs to the field of medicines, and relates to a medicinal composition for preventing and treating NITM and medical application thereof. In particular, the pharmaceutical composition is an ophthalmic pharmaceutical composition such as an ophthalmic formulation. Specifically, the invention relates to a pharmaceutical composition, which comprises 0.001-0.2% of atropine or pharmaceutically acceptable salts thereof and one or more pharmaceutically acceptable auxiliary materials; wherein the pH value of the pharmaceutical composition is 4.0-6.5; the pharmaceutical composition comprises 0.5-5% of pH regulator, wherein the pH regulator is selected from one or more of sodium dihydrogen phosphate, disodium hydrogen phosphate, citric acid, citrate, boric acid and borate. The pharmaceutical composition can effectively treat and/or prevent NITM, and has good application prospect.)